speb/financial-data huggingface dataset:
IMR.AX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -74976.00
IMR.AX cash_flow (annual, 2024-12-31) — Cash Flowsfromusedin Operating Activities Direct: -15573910.00
IMR.AX cash_flow (annual, 2024-12-31) — Changes In Cash: 14685328.00
IMR.AX cash_flow (annual, 2024-12-31) — Classesof Cash Receiptsfrom Operating Activities: -15573910.00
IMR.AX balance_sheet (annual, 2024-12-31) — Common Stock: 134902684.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Common Stock: 134902684.00
IMR.AX balance_sheet (annual, 2024-12-31) — Common Stock Equity: -7377033.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: -7377033.00
IMR.AX cash_flow (annual, 2024-12-31) — Common Stock Issuance: 32906291.00
IMR.AX cash_flow (annual, 2024-12-31) — Common Stock Payments: -1905897.00
IMR.AX income_statement (annual, 2024-12-31) — Cost Of Revenue: 1883542.00
IMR.AX balance_sheet (annual, 2024-12-31) — Current Assets: 18349437.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Current Assets: 18349437.00
IMR.AX balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 259292.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 259292.00
IMR.AX balance_sheet (annual, 2024-12-31) — Current Debt: 209137.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Current Debt: 209137.00
IMR.AX balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 468429.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 468429.00
IMR.AX balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 59519.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 59519.00
IMR.AX balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 59519.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 59519.00
IMR.AX balance_sheet (annual, 2024-12-31) — Current Liabilities: 2355913.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 2355913.00
IMR.AX income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 748165.00
IMR.AX income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 748165.00
IMR.AX income_statement (annual, 2024-12-31) — Depreciation Income Statement: 748165.00
IMR.AX balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 4667067.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 4667067.00
IMR.AX income_statement (annual, 2024-12-31) — Diluted Average Shares: 223999081.00
IMR.AX income_statement (annual, 2024-12-31) — Diluted EPS: -0.13
IMR.AX income_statement (annual, 2024-12-31) — EBIT: -29672766.00
IMR.AX income_statement (annual, 2024-12-31) — EBITDA: -28924601.00
IMR.AX cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 190889.00
IMR.AX cash_flow (annual, 2024-12-31) — End Cash Position: 15707739.00
IMR.AX balance_sheet (annual, 2024-12-31) — Financial Assets: 56243.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Financial Assets: 56243.00
IMR.AX cash_flow (annual, 2024-12-31) — Financing Cash Flow: 30334214.00
IMR.AX balance_sheet (annual, 2024-12-31) — Finished Goods: 771886.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Finished Goods: 771886.00
IMR.AX cash_flow (annual, 2024-12-31) — Free Cash Flow: -15651886.00
IMR.AX income_statement (annual, 2024-12-31) — General And Administrative Expense: 4920466.00
IMR.AX balance_sheet (annual, 2024-12-31) — Gross PPE: 6467289.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Gross PPE: 6467289.00
IMR.AX income_statement (annual, 2024-12-31) — Gross Profit: -924118.00
IMR.AX income_statement (annual, 2024-12-31) — Interest Expense: 20065.00
IMR.AX income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 20065.00
IMR.AX income_statement (annual, 2024-12-31) — Interest Income: 257718.00
IMR.AX income_statement (annual, 2024-12-31) — Interest Income Non Operating: 257718.00
IMR.AX balance_sheet (annual, 2024-12-31) — Inventory: 1502048.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Inventory: 1502048.00
IMR.AX balance_sheet (annual, 2024-12-31) — Invested Capital: 12836001.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Invested Capital: 12836001.00
IMR.AX cash_flow (annual, 2024-12-31) — Investing Cash Flow: -74976.00
IMR.AX balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 69560.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 69560.00
IMR.AX balance_sheet (annual, 2024-12-31) — Investments And Advances: 122157.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 122157.00
IMR.AX cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 32906291.00
IMR.AX cash_flow (annual, 2024-12-31) — Issuance Of Debt: 344050.00
IMR.AX balance_sheet (annual, 2024-12-31) — Leases: 1641837.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Leases: 1641837.00
IMR.AX balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 875553.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 875553.00
IMR.AX balance_sheet (annual, 2024-12-31) — Long Term Debt: 20003897.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 20003897.00
IMR.AX balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 20879450.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 20879450.00
IMR.AX cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 344050.00
IMR.AX cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -557779.00
IMR.AX balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 4107073.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 4107073.00
IMR.AX cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 31000394.00
IMR.AX balance_sheet (annual, 2024-12-31) — Net Debt: 4505295.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Net Debt: 4505295.00
IMR.AX income_statement (annual, 2024-12-31) — Net Income: -29692831.00
IMR.AX income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -29692831.00
IMR.AX income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -29692831.00
IMR.AX income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -29692831.00
IMR.AX income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -29692831.00
IMR.AX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -29692831.00
IMR.AX income_statement (annual, 2024-12-31) — Net Interest Income: 237653.00
IMR.AX cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -213729.00
IMR.AX cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -213729.00
IMR.AX income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 237653.00
IMR.AX cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -452451.00
IMR.AX balance_sheet (annual, 2024-12-31) — Net PPE: 2597130.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Net PPE: 2597130.00
IMR.AX cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -74976.00
IMR.AX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -7377033.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: -7377033.00
IMR.AX balance_sheet (annual, 2024-12-31) — Non Current Accounts Receivable: 141430.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Non Current Accounts Receivable: 141430.00
IMR.AX balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 1098533.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 1098533.00
IMR.AX balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 1098533.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Revenue: 1098533.00
IMR.AX income_statement (annual, 2024-12-31) — Normalized EBITDA: -28924601.00
IMR.AX income_statement (annual, 2024-12-31) — Normalized Income: -29692831.00
IMR.AX income_statement (annual, 2024-12-31) — Operating Income: -17063657.00
IMR.AX income_statement (annual, 2024-12-31) — Operating Revenue: 959424.00
IMR.AX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 270175766.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 270175766.00
IMR.AX cash_flow (annual, 2024-12-31) — Other Cash Receiptsfrom Operating Activities: -15573910.00
IMR.AX balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 209137.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 209137.00
IMR.AX balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 1493095.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 1493095.00
IMR.AX income_statement (annual, 2024-12-31) — Other Gand A: 4920466.00
IMR.AX income_statement (annual, 2024-12-31) — Other Income Expense: -13614992.00
IMR.AX balance_sheet (annual, 2024-12-31) — Other Investments: 52597.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Other Investments: 52597.00
IMR.AX balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 357533.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 357533.00
IMR.AX income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -13614992.00
IMR.AX income_statement (annual, 2024-12-31) — Other Operating Expenses: 18680.00
IMR.AX balance_sheet (annual, 2024-12-31) — Other Properties: 718379.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Other Properties: 718379.00
IMR.AX balance_sheet (annual, 2024-12-31) — Payables: 334870.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Payables: 334870.00
IMR.AX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 334870.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 334870.00
IMR.AX balance_sheet (annual, 2024-12-31) — Prepaid Assets: 794308.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 794308.00
IMR.AX income_statement (annual, 2024-12-31) — Pretax Income: -29692831.00
IMR.AX cash_flow (annual, 2024-12-31) — Purchase Of PPE: -77976.00
IMR.AX balance_sheet (annual, 2024-12-31) — Raw Materials: 501766.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Raw Materials: 501766.00
IMR.AX balance_sheet (annual, 2024-12-31) — Receivables: 345342.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Receivables: 345342.00
IMR.AX income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 1883542.00
IMR.AX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 748165.00
IMR.AX cash_flow (annual, 2024-12-31) — Repayment Of Debt: -557779.00
IMR.AX cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -1905897.00
IMR.AX income_statement (annual, 2024-12-31) — Research And Development: 8180184.00
IMR.AX balance_sheet (annual, 2024-12-31) — Retained Earnings: -142279717.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -142279717.00
IMR.AX cash_flow (annual, 2024-12-31) — Sale Of PPE: 3000.00
IMR.AX income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 2272044.00
IMR.AX income_statement (annual, 2024-12-31) — Selling General And Administration: 7192510.00
IMR.AX balance_sheet (annual, 2024-12-31) — Share Issued: 270175766.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Share Issued: 270175766.00
IMR.AX balance_sheet (annual, 2024-12-31) — Stockholders Equity: -7377033.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: -7377033.00
IMR.AX balance_sheet (annual, 2024-12-31) — Tangible Book Value: -7377033.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: -7377033.00
IMR.AX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
IMR.AX income_statement (annual, 2024-12-31) — Tax Provision: 0.00
IMR.AX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
IMR.AX balance_sheet (annual, 2024-12-31) — Total Assets: 21623930.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Total Assets: 21623930.00
IMR.AX balance_sheet (annual, 2024-12-31) — Total Capitalization: 12626864.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 12626864.00
IMR.AX balance_sheet (annual, 2024-12-31) — Total Debt: 21347879.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Total Debt: 21347879.00
IMR.AX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -7377033.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: -7377033.00
IMR.AX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 29000963.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 29000963.00
IMR.AX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 3274493.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 3274493.00
IMR.AX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 26645050.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 26645050.00
IMR.AX balance_sheet (annual, 2024-12-31) — Trading Securities: 69560.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Trading Securities: 69560.00
IMR.AX balance_sheet (annual, 2024-12-31) — Work In Process: 228396.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Work In Process: 228396.00
IMR.AX balance_sheet (annual, 2024-12-31) — Working Capital: 15993524.00
IMR.AX balance_sheet (quarterly, 2024-12-31) — Working Capital: 15993524.00
IMR.AX income_statement (annual, 2025-12-31) — +Operating Expense: 21590744.00
IMR.AX income_statement (annual, 2025-12-31) — +Total Revenue: 292309.00
IMR.AX balance_sheet (annual, 2025-12-31) — Accounts Payable: 496073.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 496073.00
IMR.AX balance_sheet (annual, 2025-12-31) — Accounts Receivable: 240866.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 240866.00
IMR.AX balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -4498817.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -4498817.00
IMR.AX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 15707739.00
IMR.AX cash_flow (annual, 2025-12-31) — Capital Expenditure: -434287.00
IMR.AX balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 951196.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 951196.00
IMR.AX balance_sheet (annual, 2025-12-31) — Capital Stock: 179121583.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 179121583.00
IMR.AX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 19502348.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 19502348.00
IMR.AX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 40779957.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 40779957.00
IMR.AX balance_sheet (annual, 2025-12-31) — Cash Financial: 19502348.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Cash Financial: 19502348.00
IMR.AX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 43046377.00
IMR.AX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -21711896.00
IMR.AX cash_flow (annual, 2025-12-31) — Cash Flowsfromusedin Operating Activities Direct: -19081157.00
IMR.AX cash_flow (annual, 2025-12-31) — Changes In Cash: 2253324.00
IMR.AX cash_flow (annual, 2025-12-31) — Classesof Cash Receiptsfrom Operating Activities: -19081157.00
IMR.AX balance_sheet (annual, 2025-12-31) — Common Stock: 179121583.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Common Stock: 179121583.00
IMR.AX balance_sheet (annual, 2025-12-31) — Common Stock Equity: 11523304.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 11523304.00
IMR.AX cash_flow (annual, 2025-12-31) — Common Stock Issuance: 44568544.00
IMR.AX cash_flow (annual, 2025-12-31) — Common Stock Payments: -1313030.00
IMR.AX income_statement (annual, 2025-12-31) — Cost Of Revenue: 2325837.00
IMR.AX balance_sheet (annual, 2025-12-31) — Current Assets: 42916674.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Current Assets: 42916674.00
IMR.AX balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 317153.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 317153.00
IMR.AX balance_sheet (annual, 2025-12-31) — Current Debt: 11745700.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Current Debt: 11745700.00
IMR.AX balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 12062853.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 12062853.00
IMR.AX balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 34035.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 34035.00
IMR.AX balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 34035.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 34035.00
IMR.AX balance_sheet (annual, 2025-12-31) — Current Liabilities: 17370632.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 17370632.00
IMR.AX balance_sheet (annual, 2025-12-31) — Current Provisions: 3157717.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Current Provisions: 3157717.00
IMR.AX income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 798715.00
IMR.AX income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 798715.00
IMR.AX income_statement (annual, 2025-12-31) — Depreciation Income Statement: 798715.00
IMR.AX balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 1828677.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 1828677.00
IMR.AX income_statement (annual, 2025-12-31) — EBIT: -25314393.00
IMR.AX income_statement (annual, 2025-12-31) — EBITDA: -24515678.00
IMR.AX cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 1541285.00
IMR.AX cash_flow (annual, 2025-12-31) — End Cash Position: 19502348.00
IMR.AX balance_sheet (annual, 2025-12-31) — Financial Assets: 56243.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Financial Assets: 56243.00
IMR.AX cash_flow (annual, 2025-12-31) — Financing Cash Flow: 43046377.00
IMR.AX balance_sheet (annual, 2025-12-31) — Finished Goods: 700284.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Finished Goods: 700284.00
IMR.AX cash_flow (annual, 2025-12-31) — Free Cash Flow: -19515444.00
IMR.AX income_statement (annual, 2025-12-31) — General And Administrative Expense: 5301396.00
IMR.AX balance_sheet (annual, 2025-12-31) — Gross PPE: 6641533.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Gross PPE: 6641533.00
IMR.AX income_statement (annual, 2025-12-31) — Gross Profit: -2033528.00
IMR.AX income_statement (annual, 2025-12-31) — Interest Expense: 4169.00
IMR.AX income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 4169.00
IMR.AX income_statement (annual, 2025-12-31) — Interest Income: 1180294.00
IMR.AX income_statement (annual, 2025-12-31) — Interest Income Non Operating: 1180294.00
IMR.AX balance_sheet (annual, 2025-12-31) — Inventory: 1096065.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Inventory: 1096065.00
IMR.AX balance_sheet (annual, 2025-12-31) — Invested Capital: 36537504.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 36537504.00
IMR.AX cash_flow (annual, 2025-12-31) — Investing Cash Flow: -21711896.00
IMR.AX balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 69560.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 69560.00
IMR.AX balance_sheet (annual, 2025-12-31) — Investments And Advances: 130048.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 130048.00
IMR.AX cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 44568544.00
IMR.AX balance_sheet (annual, 2025-12-31) — Leases: 1641837.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Leases: 1641837.00
IMR.AX balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 634043.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 634043.00
IMR.AX balance_sheet (annual, 2025-12-31) — Long Term Debt: 13268500.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 13268500.00
IMR.AX balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 13902543.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 13902543.00
IMR.AX cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -209137.00
IMR.AX balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 4395440.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 4395440.00
IMR.AX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 43255514.00
IMR.AX balance_sheet (annual, 2025-12-31) — Net Debt: 5511852.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Net Debt: 5511852.00
IMR.AX income_statement (annual, 2025-12-31) — Net Income: -25318562.00
IMR.AX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -25318562.00
IMR.AX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -25318562.00
IMR.AX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -25318562.00
IMR.AX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -25318562.00
IMR.AX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -25318562.00
IMR.AX income_statement (annual, 2025-12-31) — Net Interest Income: 1176125.00
IMR.AX cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -21277609.00
IMR.AX cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -209137.00
IMR.AX cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -209137.00
IMR.AX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 1176125.00
IMR.AX balance_sheet (annual, 2025-12-31) — Net PPE: 2142716.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Net PPE: 2142716.00
IMR.AX cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -434287.00
IMR.AX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 11523304.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 11523304.00
IMR.AX balance_sheet (annual, 2025-12-31) — Non Current Accounts Receivable: 95673.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 95673.00
IMR.AX balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 1085753.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 1085753.00
IMR.AX balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 1085753.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 1085753.00
IMR.AX income_statement (annual, 2025-12-31) — Normalized EBITDA: -24515678.00
IMR.AX income_statement (annual, 2025-12-31) — Normalized Income: -25318562.00
IMR.AX income_statement (annual, 2025-12-31) — Operating Income: -23624272.00
IMR.AX income_statement (annual, 2025-12-31) — Operating Revenue: 292309.00
IMR.AX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 320947028.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 320947028.00
IMR.AX cash_flow (annual, 2025-12-31) — Other Cash Receiptsfrom Operating Activities: -19081157.00
IMR.AX balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 11745700.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 11745700.00
IMR.AX income_statement (annual, 2025-12-31) — Other Gand A: 5301396.00
IMR.AX income_statement (annual, 2025-12-31) — Other Income Expense: -3669130.00
IMR.AX balance_sheet (annual, 2025-12-31) — Other Investments: 60488.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Other Investments: 60488.00
IMR.AX balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 415383.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 415383.00
IMR.AX balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 45828.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 45828.00
IMR.AX income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -3669130.00
IMR.AX income_statement (annual, 2025-12-31) — Other Operating Expenses: 34603.00
IMR.AX balance_sheet (annual, 2025-12-31) — Other Payable: 1619954.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Other Payable: 1619954.00
IMR.AX balance_sheet (annual, 2025-12-31) — Other Properties: 604256.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Other Properties: 604256.00
IMR.AX balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 21277609.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 21277609.00
IMR.AX balance_sheet (annual, 2025-12-31) — Payables: 2116027.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Payables: 2116027.00
IMR.AX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 2116027.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 2116027.00
IMR.AX balance_sheet (annual, 2025-12-31) — Prepaid Assets: 799786.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 799786.00
IMR.AX income_statement (annual, 2025-12-31) — Pretax Income: -25318562.00
IMR.AX cash_flow (annual, 2025-12-31) — Purchase Of Investment: -28683359.00
IMR.AX cash_flow (annual, 2025-12-31) — Purchase Of PPE: -434287.00
IMR.AX balance_sheet (annual, 2025-12-31) — Raw Materials: 292566.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Raw Materials: 292566.00
IMR.AX balance_sheet (annual, 2025-12-31) — Receivables: 240866.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Receivables: 240866.00
IMR.AX income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 2325837.00
IMR.AX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 798715.00
IMR.AX cash_flow (annual, 2025-12-31) — Repayment Of Debt: -209137.00
IMR.AX cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -1313030.00
IMR.AX income_statement (annual, 2025-12-31) — Research And Development: 11155766.00
IMR.AX balance_sheet (annual, 2025-12-31) — Retained Earnings: -167598279.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -167598279.00
IMR.AX cash_flow (annual, 2025-12-31) — Sale Of Investment: 7405750.00
IMR.AX income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 4300264.00
IMR.AX income_statement (annual, 2025-12-31) — Selling General And Administration: 9601660.00
IMR.AX balance_sheet (annual, 2025-12-31) — Share Issued: 320947028.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Share Issued: 320947028.00
IMR.AX balance_sheet (annual, 2025-12-31) — Stockholders Equity: 11523304.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 11523304.00
IMR.AX balance_sheet (annual, 2025-12-31) — Tangible Book Value: 11523304.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 11523304.00
IMR.AX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
IMR.AX income_statement (annual, 2025-12-31) — Tax Provision: 0.00
IMR.AX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
IMR.AX balance_sheet (annual, 2025-12-31) — Total Assets: 45756737.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Total Assets: 45756737.00
IMR.AX balance_sheet (annual, 2025-12-31) — Total Capitalization: 24791804.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 24791804.00
IMR.AX balance_sheet (annual, 2025-12-31) — Total Debt: 25965396.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Total Debt: 25965396.00
IMR.AX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 11523304.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 11523304.00
IMR.AX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 34233433.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 34233433.00
IMR.AX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 2840063.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 2840063.00
IMR.AX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 16862801.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 16862801.00
IMR.AX balance_sheet (annual, 2025-12-31) — Trading Securities: 69560.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Trading Securities: 69560.00
IMR.AX balance_sheet (annual, 2025-12-31) — Work In Process: 103215.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Work In Process: 103215.00
IMR.AX balance_sheet (annual, 2025-12-31) — Working Capital: 25546042.00
IMR.AX balance_sheet (quarterly, 2025-12-31) — Working Capital: 25546042.00
IMR.V income_statement (annual, 2022-05-31) — +Operating Expense: 1727696.00
IMR.V income_statement (annual, 2022-05-31) — +Total Revenue: 0.00
IMR.V balance_sheet (annual, 2022-05-31) — Accounts Payable: 47702.00
IMR.V balance_sheet (annual, 2022-05-31) — Accounts Receivable: 19359.00
IMR.V balance_sheet (annual, 2022-05-31) — Accumulated Depreciation: -20577.00
IMR.V cash_flow (annual, 2022-05-31) — Asset Impairment Charge: 7162.00
IMR.V income_statement (annual, 2022-05-31) — Basic Average Shares: 1433459.00
IMR.V income_statement (annual, 2022-05-31) — Basic EPS: -1.20
IMR.V cash_flow (annual, 2022-05-31) — Beginning Cash Position: 882471.00
IMR.V cash_flow (annual, 2022-05-31) — Capital Expenditure: -374074.00
IMR.V balance_sheet (annual, 2022-05-31) — Capital Stock: 46179894.00
IMR.V balance_sheet (annual, 2022-05-31) — Cash And Cash Equivalents: 1984495.00
IMR.V balance_sheet (annual, 2022-05-31) — Cash Cash Equivalents And Short Term Investments: 1984495.00
IMR.V balance_sheet (annual, 2022-05-31) — Cash Financial: 1984495.00
IMR.V cash_flow (annual, 2022-05-31) — Cash Flow From Continuing Financing Activities: 2838452.00
IMR.V cash_flow (annual, 2022-05-31) — Cash Flow From Continuing Investing Activities: -374074.00
IMR.V cash_flow (annual, 2022-05-31) — Cash Flow From Continuing Operating Activities: -1362354.00
IMR.V cash_flow (annual, 2022-05-31) — Change In Account Payable: -195683.00
IMR.V cash_flow (annual, 2022-05-31) — Change In Payable: -201816.00
IMR.V cash_flow (annual, 2022-05-31) — Change In Payables And Accrued Expense: -201816.00
IMR.V cash_flow (annual, 2022-05-31) — Change In Prepaid Assets: 35368.00
IMR.V cash_flow (annual, 2022-05-31) — Change In Receivables: -685.00
IMR.V cash_flow (annual, 2022-05-31) — Change In Working Capital: -167133.00
IMR.V cash_flow (annual, 2022-05-31) — Changes In Cash: 1102024.00
IMR.V balance_sheet (annual, 2022-05-31) — Common Stock: 46179894.00
IMR.V balance_sheet (annual, 2022-05-31) — Common Stock Equity: 6214930.00
IMR.V cash_flow (annual, 2022-05-31) — Common Stock Issuance: 3000000.00
IMR.V income_statement (annual, 2022-05-31) — Cost Of Revenue: 3628.00
IMR.V balance_sheet (annual, 2022-05-31) — Current Assets: 2071045.00
IMR.V balance_sheet (annual, 2022-05-31) — Current Debt: 9545.00
IMR.V balance_sheet (annual, 2022-05-31) — Current Debt And Capital Lease Obligation: 9545.00
IMR.V balance_sheet (annual, 2022-05-31) — Current Liabilities: 244538.00
IMR.V balance_sheet (annual, 2022-05-31) — Current Notes Payable: 9545.00
IMR.V cash_flow (annual, 2022-05-31) — Depreciation: 3628.00
IMR.V cash_flow (annual, 2022-05-31) — Depreciation Amortization Depletion: 3628.00
IMR.V cash_flow (annual, 2022-05-31) — Depreciation And Amortization: 3628.00
IMR.V income_statement (annual, 2022-05-31) — Diluted Average Shares: 1433459.00
IMR.V income_statement (annual, 2022-05-31) — Diluted EPS: -1.20
IMR.V income_statement (annual, 2022-05-31) — Diluted NI Availto Com Stockholders: -1656691.00
IMR.V balance_sheet (annual, 2022-05-31) — Dueto Related Parties Current: 0.00
IMR.V income_statement (annual, 2022-05-31) — EBIT: -1656191.00
IMR.V income_statement (annual, 2022-05-31) — EBITDA: -1652563.00
IMR.V cash_flow (annual, 2022-05-31) — End Cash Position: 1984495.00
IMR.V cash_flow (annual, 2022-05-31) — Financing Cash Flow: 2838452.00
IMR.V cash_flow (annual, 2022-05-31) — Free Cash Flow: -1736428.00
IMR.V balance_sheet (annual, 2022-05-31) — Gains Losses Not Affecting Retained Earnings: 4638719.00
IMR.V income_statement (annual, 2022-05-31) — General And Administrative Expense: 947143.00
IMR.V balance_sheet (annual, 2022-05-31) — Gross PPE: 4409000.00
IMR.V income_statement (annual, 2022-05-31) — Gross Profit: -3628.00
IMR.V income_statement (annual, 2022-05-31) — Impairment Of Capital Assets: 7162.00
IMR.V income_statement (annual, 2022-05-31) — Interest Expense: 500.00
IMR.V income_statement (annual, 2022-05-31) — Interest Expense Non Operating: 500.00
IMR.V balance_sheet (annual, 2022-05-31) — Invested Capital: 6224475.00
IMR.V cash_flow (annual, 2022-05-31) — Investing Cash Flow: -374074.00
IMR.V cash_flow (annual, 2022-05-31) — Issuance Of Capital Stock: 3000000.00
IMR.V balance_sheet (annual, 2022-05-31) — Machinery Furniture Equipment: 29046.00
IMR.V cash_flow (annual, 2022-05-31) — Net Common Stock Issuance: 3000000.00
IMR.V income_statement (annual, 2022-05-31) — Net Income: -1656691.00
IMR.V income_statement (annual, 2022-05-31) — Net Income Common Stockholders: -1656691.00
IMR.V income_statement (annual, 2022-05-31) — Net Income Continuous Operations: -1656691.00
IMR.V income_statement (annual, 2022-05-31) — Net Income From Continuing And Discontinued Operation: -1656691.00
IMR.V income_statement (annual, 2022-05-31) — Net Income From Continuing Operation Net Minority Interest: -1656691.00
IMR.V cash_flow (annual, 2022-05-31) — Net Income From Continuing Operations: -1656691.00
IMR.V income_statement (annual, 2022-05-31) — Net Income Including Noncontrolling Interests: -1656691.00
IMR.V income_statement (annual, 2022-05-31) — Net Interest Income: -500.00
IMR.V income_statement (annual, 2022-05-31) — Net Non Operating Interest Income Expense: -500.00
IMR.V cash_flow (annual, 2022-05-31) — Net Other Financing Charges: -161548.00
IMR.V balance_sheet (annual, 2022-05-31) — Net PPE: 4388423.00
IMR.V cash_flow (annual, 2022-05-31) — Net PPE Purchase And Sale: -374074.00
IMR.V balance_sheet (annual, 2022-05-31) — Net Tangible Assets: 6214930.00
IMR.V income_statement (annual, 2022-05-31) — Normalized EBITDA: -1705578.00
IMR.V income_statement (annual, 2022-05-31) — Normalized Income: -1709706.00
IMR.V cash_flow (annual, 2022-05-31) — Operating Cash Flow: -1362354.00
IMR.V cash_flow (annual, 2022-05-31) — Operating Gains Losses: 60177.00
IMR.V income_statement (annual, 2022-05-31) — Operating Income: -1731324.00
IMR.V income_statement (annual, 2022-05-31) — Operating Revenue: 0.00
IMR.V balance_sheet (annual, 2022-05-31) — Ordinary Shares Number: 3717939.00
IMR.V balance_sheet (annual, 2022-05-31) — Other Current Liabilities: 187291.00
IMR.V income_statement (annual, 2022-05-31) — Other Gand A: 535022.00
IMR.V income_statement (annual, 2022-05-31) — Other Income Expense: 75133.00
IMR.V cash_flow (annual, 2022-05-31) — Other Non Cash Items: -21618.00
IMR.V income_statement (annual, 2022-05-31) — Other Non Operating Income Expenses: 22118.00
IMR.V income_statement (annual, 2022-05-31) — Other Operating Expenses: 78177.00
IMR.V balance_sheet (annual, 2022-05-31) — Other Properties: 4379954.00
IMR.V income_statement (annual, 2022-05-31) — Other Special Charges: -60177.00
IMR.V balance_sheet (annual, 2022-05-31) — Payables: 47702.00
IMR.V balance_sheet (annual, 2022-05-31) — Payables And Accrued Expenses: 47702.00
IMR.V balance_sheet (annual, 2022-05-31) — Prepaid Assets: 67191.00
IMR.V income_statement (annual, 2022-05-31) — Pretax Income: -1656691.00
IMR.V cash_flow (annual, 2022-05-31) — Proceeds From Stock Option Exercised: 0.00
IMR.V cash_flow (annual, 2022-05-31) — Purchase Of PPE: -374074.00
IMR.V balance_sheet (annual, 2022-05-31) — Receivables: 19359.00
IMR.V income_statement (annual, 2022-05-31) — Reconciled Cost Of Revenue: 3628.00
IMR.V income_statement (annual, 2022-05-31) — Reconciled Depreciation: 3628.00
IMR.V balance_sheet (annual, 2022-05-31) — Retained Earnings: -44603683.00
IMR.V income_statement (annual, 2022-05-31) — Salaries And Wages: 412121.00
IMR.V income_statement (annual, 2022-05-31) — Selling And Marketing Expense: 702376.00
IMR.V income_statement (annual, 2022-05-31) — Selling General And Administration: 1649519.00
IMR.V balance_sheet (annual, 2022-05-31) — Share Issued: 3717939.00
IMR.V income_statement (annual, 2022-05-31) — Special Income Charges: 53015.00
IMR.V cash_flow (annual, 2022-05-31) — Stock Based Compensation: 412121.00
IMR.V balance_sheet (annual, 2022-05-31) — Stockholders Equity: 6214930.00
IMR.V balance_sheet (annual, 2022-05-31) — Tangible Book Value: 6214930.00
IMR.V income_statement (annual, 2022-05-31) — Tax Effect Of Unusual Items: 0.00
IMR.V income_statement (annual, 2022-05-31) — Tax Rate For Calcs: 0.00
IMR.V balance_sheet (annual, 2022-05-31) — Total Assets: 6459468.00
IMR.V balance_sheet (annual, 2022-05-31) — Total Capitalization: 6214930.00
IMR.V balance_sheet (annual, 2022-05-31) — Total Debt: 9545.00
IMR.V balance_sheet (annual, 2022-05-31) — Total Equity Gross Minority Interest: 6214930.00
IMR.V income_statement (annual, 2022-05-31) — Total Expenses: 1731324.00
IMR.V balance_sheet (annual, 2022-05-31) — Total Liabilities Net Minority Interest: 244538.00
IMR.V balance_sheet (annual, 2022-05-31) — Total Non Current Assets: 4388423.00
IMR.V balance_sheet (annual, 2022-05-31) — Total Non Current Liabilities Net Minority Interest: 0.00
IMR.V income_statement (annual, 2022-05-31) — Total Operating Income As Reported: -1731824.00
IMR.V income_statement (annual, 2022-05-31) — Total Unusual Items: 53015.00
IMR.V income_statement (annual, 2022-05-31) — Total Unusual Items Excluding Goodwill: 53015.00
IMR.V balance_sheet (annual, 2022-05-31) — Working Capital: 1826507.00
IMR.V income_statement (annual, 2023-05-31) — +Operating Expense: 2439341.00
IMR.V income_statement (annual, 2023-05-31) — +Total Revenue: 0.00
IMR.V balance_sheet (annual, 2023-05-31) — Accounts Payable: 246458.00
IMR.V balance_sheet (annual, 2023-05-31) — Accounts Receivable: 96852.00
IMR.V balance_sheet (annual, 2023-05-31) — Accumulated Depreciation: -23118.00
IMR.V cash_flow (annual, 2023-05-31) — Asset Impairment Charge: 0.00
IMR.V income_statement (annual, 2023-05-31) — Basic Average Shares: 4059697.00
IMR.V income_statement (annual, 2023-05-31) — Basic EPS: -0.53
IMR.V cash_flow (annual, 2023-05-31) — Beginning Cash Position: 1984495.00
IMR.V cash_flow (annual, 2023-05-31) — Capital Expenditure: -1798957.00
IMR.V balance_sheet (annual, 2023-05-31) — Capital Stock: 49133964.00
IMR.V balance_sheet (annual, 2023-05-31) — Cash And Cash Equivalents: 893539.00
IMR.V balance_sheet (annual, 2023-05-31) — Cash Cash Equivalents And Short Term Investments: 893539.00
IMR.V balance_sheet (annual, 2023-05-31) — Cash Financial: 893539.00
IMR.V cash_flow (annual, 2023-05-31) — Cash Flow From Continuing Financing Activities: 3041243.00
IMR.V cash_flow (annual, 2023-05-31) — Cash Flow From Continuing Investing Activities: -1798957.00
IMR.V cash_flow (annual, 2023-05-31) — Cash Flow From Continuing Operating Activities: -2333242.00
IMR.V cash_flow (annual, 2023-05-31) — Change In Account Payable: 111811.00
IMR.V cash_flow (annual, 2023-05-31) — Change In Payable: 143282.00
IMR.V cash_flow (annual, 2023-05-31) — Change In Payables And Accrued Expense: 143282.00
IMR.V cash_flow (annual, 2023-05-31) — Change In Prepaid Assets: -76569.00
IMR.V cash_flow (annual, 2023-05-31) — Change In Receivables: -77493.00
IMR.V cash_flow (annual, 2023-05-31) — Change In Working Capital: -10780.00
IMR.V cash_flow (annual, 2023-05-31) — Changes In Cash: -1090956.00
IMR.V balance_sheet (annual, 2023-05-31) — Common Stock: 49133964.00
IMR.V balance_sheet (annual, 2023-05-31) — Common Stock Equity: 7019207.00
IMR.V cash_flow (annual, 2023-05-31) — Common Stock Issuance: 1883250.00
IMR.V income_statement (annual, 2023-05-31) — Cost Of Revenue: 2541.00
IMR.V balance_sheet (annual, 2023-05-31) — Current Assets: 1134151.00
IMR.V balance_sheet (annual, 2023-05-31) — Current Liabilities: 402728.00
IMR.V balance_sheet (annual, 2023-05-31) — Current Notes Payable: 0.00
IMR.V cash_flow (annual, 2023-05-31) — Depreciation: 2541.00
IMR.V cash_flow (annual, 2023-05-31) — Depreciation Amortization Depletion: 2541.00
IMR.V cash_flow (annual, 2023-05-31) — Depreciation And Amortization: 2541.00
IMR.V income_statement (annual, 2023-05-31) — Diluted Average Shares: 4059697.00
IMR.V income_statement (annual, 2023-05-31) — Diluted EPS: -0.53
IMR.V income_statement (annual, 2023-05-31) — Diluted NI Availto Com Stockholders: -2145220.00
IMR.V balance_sheet (annual, 2023-05-31) — Dueto Related Parties Current: 31471.00
IMR.V income_statement (annual, 2023-05-31) — EBIT: -2145220.00
IMR.V income_statement (annual, 2023-05-31) — EBITDA: -2142679.00
IMR.V cash_flow (annual, 2023-05-31) — End Cash Position: 893539.00
IMR.V cash_flow (annual, 2023-05-31) — Financing Cash Flow: 3041243.00
IMR.V cash_flow (annual, 2023-05-31) — Free Cash Flow: -4132199.00
IMR.V balance_sheet (annual, 2023-05-31) — Gains Losses Not Affecting Retained Earnings: 4634146.00
IMR.V income_statement (annual, 2023-05-31) — General And Administrative Expense: 711631.00
IMR.V balance_sheet (annual, 2023-05-31) — Gross PPE: 6310902.00
IMR.V income_statement (annual, 2023-05-31) — Gross Profit: -2541.00
IMR.V income_statement (annual, 2023-05-31) — Impairment Of Capital Assets: 0.00
IMR.V income_statement (annual, 2023-05-31) — Interest Expense: 0.00
IMR.V income_statement (annual, 2023-05-31) — Interest Expense Non Operating: 0.00
IMR.V balance_sheet (annual, 2023-05-31) — Invested Capital: 7019207.00
IMR.V cash_flow (annual, 2023-05-31) — Investing Cash Flow: -1798957.00
IMR.V cash_flow (annual, 2023-05-31) — Issuance Of Capital Stock: 1883250.00
IMR.V balance_sheet (annual, 2023-05-31) — Machinery Furniture Equipment: 29046.00
IMR.V cash_flow (annual, 2023-05-31) — Net Common Stock Issuance: 1883250.00
IMR.V income_statement (annual, 2023-05-31) — Net Income: -2145220.00
IMR.V income_statement (annual, 2023-05-31) — Net Income Common Stockholders: -2145220.00
IMR.V income_statement (annual, 2023-05-31) — Net Income Continuous Operations: -2145220.00
IMR.V income_statement (annual, 2023-05-31) — Net Income From Continuing And Discontinued Operation: -2145220.00
IMR.V income_statement (annual, 2023-05-31) — Net Income From Continuing Operation Net Minority Interest: -2145220.00
IMR.V cash_flow (annual, 2023-05-31) — Net Income From Continuing Operations: -2145220.00
IMR.V income_statement (annual, 2023-05-31) — Net Income Including Noncontrolling Interests: -2145220.00
IMR.V income_statement (annual, 2023-05-31) — Net Interest Income: 0.00
IMR.V income_statement (annual, 2023-05-31) — Net Non Operating Interest Income Expense: 0.00
IMR.V cash_flow (annual, 2023-05-31) — Net Other Financing Charges: -87140.00
IMR.V balance_sheet (annual, 2023-05-31) — Net PPE: 6287784.00
IMR.V cash_flow (annual, 2023-05-31) — Net PPE Purchase And Sale: -1798957.00
IMR.V balance_sheet (annual, 2023-05-31) — Net Tangible Assets: 7019207.00
IMR.V income_statement (annual, 2023-05-31) — Normalized EBITDA: -2152224.00
IMR.V income_statement (annual, 2023-05-31) — Normalized Income: -2154765.00
IMR.V cash_flow (annual, 2023-05-31) — Operating Cash Flow: -2333242.00
IMR.V cash_flow (annual, 2023-05-31) — Operating Gains Losses: -9545.00
IMR.V income_statement (annual, 2023-05-31) — Operating Income: -2441882.00
IMR.V income_statement (annual, 2023-05-31) — Operating Revenue: 0.00
IMR.V balance_sheet (annual, 2023-05-31) — Ordinary Shares Number: 5088006.00
IMR.V balance_sheet (annual, 2023-05-31) — Other Current Liabilities: 124799.00
IMR.V income_statement (annual, 2023-05-31) — Other Gand A: 594752.00
IMR.V income_statement (annual, 2023-05-31) — Other Income Expense: 296662.00
IMR.V cash_flow (annual, 2023-05-31) — Other Non Cash Items: -287117.00
IMR.V income_statement (annual, 2023-05-31) — Other Non Operating Income Expenses: 287117.00
IMR.V income_statement (annual, 2023-05-31) — Other Operating Expenses: 123296.00
IMR.V balance_sheet (annual, 2023-05-31) — Other Properties: 6281856.00
IMR.V income_statement (annual, 2023-05-31) — Other Special Charges: -9545.00
IMR.V balance_sheet (annual, 2023-05-31) — Payables: 277929.00
IMR.V balance_sheet (annual, 2023-05-31) — Payables And Accrued Expenses: 277929.00
IMR.V balance_sheet (annual, 2023-05-31) — Prepaid Assets: 143760.00
IMR.V income_statement (annual, 2023-05-31) — Pretax Income: -2145220.00
IMR.V cash_flow (annual, 2023-05-31) — Proceeds From Stock Option Exercised: 1245133.00
IMR.V cash_flow (annual, 2023-05-31) — Purchase Of PPE: -1798957.00
IMR.V balance_sheet (annual, 2023-05-31) — Receivables: 96852.00
IMR.V income_statement (annual, 2023-05-31) — Reconciled Cost Of Revenue: 2541.00
IMR.V income_statement (annual, 2023-05-31) — Reconciled Depreciation: 2541.00
IMR.V income_statement (annual, 2023-05-31) — Rent And Landing Fees: 0.00
IMR.V income_statement (annual, 2023-05-31) — Rent Expense Supplemental: 0.00
IMR.V balance_sheet (annual, 2023-05-31) — Retained Earnings: -46748903.00
IMR.V income_statement (annual, 2023-05-31) — Salaries And Wages: 116879.00
IMR.V income_statement (annual, 2023-05-31) — Selling And Marketing Expense: 1604414.00
IMR.V income_statement (annual, 2023-05-31) — Selling General And Administration: 2316045.00
IMR.V balance_sheet (annual, 2023-05-31) — Share Issued: 5088006.00
IMR.V income_statement (annual, 2023-05-31) — Special Income Charges: 9545.00
IMR.V cash_flow (annual, 2023-05-31) — Stock Based Compensation: 116879.00
IMR.V balance_sheet (annual, 2023-05-31) — Stockholders Equity: 7019207.00
IMR.V balance_sheet (annual, 2023-05-31) — Tangible Book Value: 7019207.00
IMR.V income_statement (annual, 2023-05-31) — Tax Effect Of Unusual Items: 0.00
IMR.V income_statement (annual, 2023-05-31) — Tax Rate For Calcs: 0.00
IMR.V balance_sheet (annual, 2023-05-31) — Total Assets: 7421935.00
IMR.V balance_sheet (annual, 2023-05-31) — Total Capitalization: 7019207.00
IMR.V balance_sheet (annual, 2023-05-31) — Total Equity Gross Minority Interest: 7019207.00
IMR.V income_statement (annual, 2023-05-31) — Total Expenses: 2441882.00
IMR.V balance_sheet (annual, 2023-05-31) — Total Liabilities Net Minority Interest: 402728.00
IMR.V balance_sheet (annual, 2023-05-31) — Total Non Current Assets: 6287784.00
IMR.V balance_sheet (annual, 2023-05-31) — Total Non Current Liabilities Net Minority Interest: 0.00
IMR.V income_statement (annual, 2023-05-31) — Total Operating Income As Reported: -2441882.00
IMR.V income_statement (annual, 2023-05-31) — Total Unusual Items: 9545.00
IMR.V income_statement (annual, 2023-05-31) — Total Unusual Items Excluding Goodwill: 9545.00
IMR.V balance_sheet (annual, 2023-05-31) — Working Capital: 731423.00
IMR.V income_statement (annual, 2024-05-31) — +Operating Expense: 1099487.00
IMR.V income_statement (annual, 2024-05-31) — +Total Revenue: 0.00
IMR.V balance_sheet (annual, 2024-05-31) — Accounts Payable: 434277.00
IMR.V balance_sheet (annual, 2024-05-31) — Accounts Receivable: 8630.00
IMR.V balance_sheet (annual, 2024-05-31) — Accumulated Depreciation: -24896.00
IMR.V cash_flow (annual, 2024-05-31) — Asset Impairment Charge: 1189513.00
IMR.V income_statement (annual, 2024-05-31) — Basic Average Shares: 5329490.00
IMR.V income_statement (annual, 2024-05-31) — Basic EPS: -0.43
IMR.V cash_flow (annual, 2024-05-31) — Beginning Cash Position: 893539.00
IMR.V cash_flow (annual, 2024-05-31) — Capital Expenditure: -393623.00
IMR.V balance_sheet (annual, 2024-05-31) — Capital Stock: 49454484.00
IMR.V balance_sheet (annual, 2024-05-31) — Cash And Cash Equivalents: 12369.00
IMR.V balance_sheet (annual, 2024-05-31) — Cash Cash Equivalents And Short Term Investments: 12369.00
IMR.V balance_sheet (annual, 2024-05-31) — Cash Financial: 12369.00
IMR.V cash_flow (annual, 2024-05-31) — Cash Flow From Continuing Financing Activities: 338520.00
IMR.V cash_flow (annual, 2024-05-31) — Cash Flow From Continuing Investing Activities: -393623.00
IMR.V cash_flow (annual, 2024-05-31) — Cash Flow From Continuing Operating Activities: -826067.00
IMR.V cash_flow (annual, 2024-05-31) — Change In Account Payable: -31944.00